Douglas Evan Godshall - 13 May 2022 Form 4 Insider Report for Shockwave Medical, Inc.

Role: President & CEO, Director
Signature: /s/ Wade Estey, as attorney-in-fact for Douglas Godshall
Issuer symbol: N/A
Transactions as of: 13 May 2022
Net transactions value: -$732,920
Form type: 4
Filing time: 13 May 2022, 20:19:20 UTC
Previous filing: 12 May 2022
Next filing: 01 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWAV	Common Stock	Options Exercise	$17,080	+5,000	+3.5%	$3.42	147,926	13 May 2022	Direct	F1
transaction	SWAV	Common Stock	Sale	$750,000	-5,000	-3.4%	$150.00	142,926	13 May 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SWAV	Stock Option	Options Exercise	$0	-5,000	-1.1%	$0.000000	464,799	13 May 2022	Common Stock	5,000	$3.42	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 2/27/2022.
F2	All reported securities were sold at a price of $150.00.
F3	Twenty-Five percent of the shares subject to this option vested on 5/9/18 and the balance of the shares are scheduled to vest in equal monthly installments thereafter for 36 months.